Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

Director/PDMR Shareholding

31 Dec 2018 07:00

RNS Number : 7744L
Ovoca Bio PLC
31 December 2018
Β 

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

Β 

Β This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

Β 

a)

Name

Β 

Nikolay Myasoedov

Β 

Β 

Β 

Β 

2

Reason for the notification

Β 

a)

Position/status

Β 

Non-Executive Director, PDMR

Β 

Β 

Β 

b)

Initial Notification Amendment

Β 

Initial Notification

Β 

Β 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ovoca Bio plc

Β 

b)

LEI

213800ST2AK5XQ1O5207

Β 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument,

type of

instrument

Identification code

Β 

Ordinary Shares of nominal value €0.125 each

Β 

ISIN: IE00B4XVDC01

b)

Nature of the transaction

Β 

Acquisition of Ordinary Shares

Β 

Β 

Β 

Β 

Β 

Β 

Β 

c)

Price(s) and volume(s)

Β 

Price(s)

Volume(s)

8 pence

1,654,125

Β 

Β 

d)

Aggregated information

- Aggregated volume

- Price

Β 

Β 

N/A (Single Transaction)

Β 

Β 

Β 

e)

Date of the transaction

Β 

28 December 2018

Β 

Β 

f)

Place of the transaction

Β 

Outside of a trading venue

Β 

g)

Additional Information

Following this transaction, Mr Myasoedov holds

1,654,125 Ordinary Shares in the Company, or approximately 2.0%

Β 

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

Β 

Β This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

Β 

a)

Name

Β 

Yuri Radchenko

Β 

Β 

Β 

Β 

2

Reason for the notification

Β 

a)

Position/status

Β 

Non-Executive Director, PDMR

Β 

Β 

Β 

b)

Initial Notification Amendment

Β 

Initial Notification

Β 

Β 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ovoca Bio plc

Β 

b)

LEI

213800ST2AK5XQ1O5207

Β 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument,

type of

instrument

Identification code

Β 

Ordinary Shares of nominal value €0.125 each

Β 

ISIN: IE00B4XVDC01

b)

Nature of the transaction

Β 

Disposal of Ordinary Shares

Β 

Β 

Β 

Β 

Β 

Β 

Β 

c)

Price(s) and volume(s)

Β 

Price(s)

Volume(s)

8 pence

1,654,125

Β 

Β 

d)

Aggregated information

- Aggregated volume

- Price

Β 

Β 

N/A (Single Transaction)

Β 

Β 

Β 

e)

Date of the transaction

Β 

28 December 2018

Β 

Β 

f)

Place of the transaction

Β 

Outside of a trading venue

Β 

g)

Additional Information

Following this transaction, Mr Radchenko holds 10,002,077 Ordinary Shares in the Company, or approximately 12.3%

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHEAKAEDFKPFFF
Date   Source Headline
5th Feb 20267:00 amRNSChange of Name
28th Jan 20268:00 amRNSReadmission - Ovoca Bio PLC
28th Jan 20267:00 amRNSFirst Day of Dealings on AIM
27th Jan 20262:32 pmRNSResult of Meeting
31st Dec 20258:00 amRNSSchedule One - Ovoca Bio Plc
31st Dec 20258:00 amRNSSchedule One - Ovoca Bio Plc
31st Dec 20257:00 amRNSNotice of AGM
31st Dec 20257:00 amRNSPublication of Admission Document
31st Dec 20257:00 amRNSPublication of Admission Document
31st Dec 20257:00 amRNSNotice of AGM
13th Nov 20257:00 amRNSChange of Broker
30th Sep 20251:09 pmRNSReplacement Half Year Report
30th Sep 20257:00 amRNSHalf-year Report
26th Jun 20257:00 amRNSPublication of 2024 Annual Report
5th Jun 20257:00 amRNSDelisting from Euronext Growth Exchange
7th May 20257:30 amRNSSuspension - Ovoca Bio plc
7th May 20257:00 amRNSProposed Acquisition, Disposal & Reverse Takeover
3rd Mar 20252:00 pmRNSManagement Changes
18th Dec 20246:00 pmRNSResult of AGM
18th Nov 20247:00 amRNSNotice of AGM
11th Oct 20245:30 pmRNSHolding(s) in Company
9th Oct 20245:45 pmRNSSale of Treasury Shares
25th Sep 20247:00 amRNSHalf-year Report
2nd Sep 20242:30 pmRNSConsultancy Agreement
15th Jul 20247:00 amRNSDirector/PDMR Shareholding
15th Jul 20247:00 amRNSDirectorate Change
28th Jun 20247:00 amRNSAnnual Financial Report
23rd Jan 20247:00 amRNSHolding(s) in Company
1st Dec 202312:00 pmRNSResult of AGM
7th Nov 20239:15 amRNSNotice of AGM
28th Sep 20237:00 amRNSInterim Results
31st Aug 20237:00 amRNSSummary Results of Phase II Study for Orenetide
30th Jun 20237:00 amRNSAnnual Financial Report
12th Jun 20237:00 amRNSUpdate on Completion Timelines for Phase II Study
16th Mar 20234:35 pmRNSPrice Monitoring Extension
16th Mar 20232:05 pmRNSSecond Price Monitoring Extn
16th Mar 20232:00 pmRNSPrice Monitoring Extension
16th Mar 20239:05 amRNSSecond Price Monitoring Extn
16th Mar 20239:00 amRNSPrice Monitoring Extension
8th Mar 20237:00 amRNSDisposal of Russian Assets
14th Feb 20234:41 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20232:05 pmRNSSecond Price Monitoring Extn
14th Feb 20232:00 pmRNSPrice Monitoring Extension
13th Feb 20239:00 amRNSPrice Monitoring Extension
13th Jan 202311:05 amRNSSecond Price Monitoring Extn
13th Jan 202311:00 amRNSPrice Monitoring Extension
28th Oct 20227:00 amRNSResult of AGM
6th Oct 20222:30 pmRNSNotice of AGM
30th Sep 20227:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.